|
Q4 FY2017
As of Dec 29, 2017
|
Q3 FY2017
As of Sep 29, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Jan 25, 2017
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jul 1, 2016
|
Q1 FY2016
As of Apr 1, 2016
|
Q4 FY2015
As of Jan 1, 2016
|
Q3 FY2015
As of Oct 2, 2015
|
Q2 FY2015
As of Jul 3, 2015
|
Q1 FY2015
As of Apr 3, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable - net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| TOTAL CURRENT ASSETS | ||||||||||||||||||||
| PROPERTY AND EQUIPMENT - NET | ||||||||||||||||||||
| GOODWILL | ||||||||||||||||||||
| OTHER INTANGIBLE ASSETS - NET | ||||||||||||||||||||
| ASSETS HELD FOR SALE | ||||||||||||||||||||
| OTHER ASSETS | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued other liabilities | ||||||||||||||||||||
| Current portion - Seller Notes | ||||||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||||||
| LONG-TERM LIABILITIES: | ||||||||||||||||||||
| Revolving credit facility | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Seller notes, net of current portion | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| TOTAL LONG-TERM LIABILITIES | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| NONCONTROLLING INTEREST - REDEEMABLE - | ||||||||||||||||||||
| HEALTHCARE INNOVATIONS | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY: | ||||||||||||||||||||
| Common stock, par value $0.10; authorized 25,000; 14,243 and 10,504 issued and outstanding | ||||||||||||||||||||
| Treasury stock, at cost, 114 and 103 shares | ||||||||||||||||||||
| Treasury stock, at cost, 251 and 117 shares | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Almost Family, Inc. stockholders' equity | ||||||||||||||||||||
| Noncontrolling interests - nonredeemable | ||||||||||||||||||||
| TOTAL STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
